Hiromichi Kimura

After working at the pharmaceutical division of Kyowa Hakko Kogyo and J.P. Morgan as Vice President, Mergers & Acquisitions Division, Dr. Kimura became President and Representative Director of Amersham Pharmacia Biotech KK (present: GE Healthcare Japan), Monsanto Japan Ltd. (present: Pfizer Japan Inc.), and subsequently CEO of HuBit Genomix Inc.

In March 2004, Dr. Kimura co-founded Fast Track Initiative (FTI) Inc. and became President of the partnership.

Graduated from the faculty of pharmaceutical sciences, the University of Tokyo.

Ph.D. in pharmaceutical sciences from the University of Tokyo

Doctor of Pharmacy

MBA from the Graduate School of Business, Stanford University